Amanote Research

Amanote Research

    RegisterSign In

P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?

Frontiers in Chemistry - Switzerland
doi 10.3389/fchem.2018.00248
Full Text
Open PDF
Abstract

Available in full text

Categories
Chemistry
Date

June 28, 2018

Authors
Chris N. J. YoungDariusz C. Górecki
Publisher

Frontiers Media SA


Related search

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

The 5-HT3receptor as a Therapeutic Target

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2007English

Candida Albicansdimorphism as a Therapeutic Target

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Tumor Evolution as a Therapeutic Target

Cancer Discovery
Oncology
2017English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Prostanoid Receptor EP2 as a Therapeutic Target

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

Tax as a Therapeutic Target in ATL

Retrovirology
VirologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy